Xeljanz (tofacitinib) Extended Release (XR) Tablets

Xeljanz

Company:  Pfizer, Inc.
Application No.:  208246
Approval Date: 02/23/2016

Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.

 

Date created: June 26, 2017

Back to Top    Drugs@FDA

Vision impaired people having problems accessing certain pages of a PDF file may call (301) 796-3634 for assistance.

Note: Documents in PDF format require the Adobe Acrobat Reader®.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English